Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khosrow Kashfi

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Biochemical Pharmacology|February 6, 2018
The dichotomous role of H<sub>2</sub>S in cancer cell biology? Déjà vu all over againKhosrow Kashfi
Critical Reviews in Oncogenesis|October 12, 2023
Fifty Years of Diazeniumdiolate Research: A Tribute to Dr. Larry K. KeeferKhosrow Kashfi
Forum on Immunopathological Diseases and Therapeutics|June 5, 2013
Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-NitrosylationKhosrow Kashfi
Antioxidants & Redox Signaling|April 16, 2013
Anti-cancer activity of new designer hydrogen sulfide-donating hybridsKhosrow Kashfi
Redox Biology|February 7, 2017
Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer AgentsKhosrow Kashfi
Advances in Pharmacology (San Diego, Calif.)|March 17, 2010
Anti-inflammatory agents as cancer therapeuticsKhosrow Kashfi
Trends in Molecular Medicine|July 10, 2004
Nitric-oxide-donating NSAIDs as agents for cancer preventionBasil Rigas, Khosrow Kashfi
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2005
Cancer prevention: a new era beyond cyclooxygenase-2Basil Rigas, Khosrow Kashfi
Biochemical and Biophysical Research Communications|May 22, 2007
The mechanism of action of nitric oxide-donating aspirinKhosrow Kashfi, Basil Rigas
Biochemical Pharmacology|March 8, 2020
Tumor associated macrophages and 'NO'Niharika Nath, Khosrow Kashfi
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Biochemical Pharmacology|February 6, 2018
The dichotomous role of H<sub>2</sub>S in cancer cell biology? Déjà vu all over againKhosrow Kashfi
Critical Reviews in Oncogenesis|October 12, 2023
Fifty Years of Diazeniumdiolate Research: A Tribute to Dr. Larry K. KeeferKhosrow Kashfi
Forum on Immunopathological Diseases and Therapeutics|June 5, 2013
Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-NitrosylationKhosrow Kashfi
Antioxidants & Redox Signaling|April 16, 2013
Anti-cancer activity of new designer hydrogen sulfide-donating hybridsKhosrow Kashfi
Redox Biology|February 7, 2017
Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer AgentsKhosrow Kashfi
Advances in Pharmacology (San Diego, Calif.)|March 17, 2010
Anti-inflammatory agents as cancer therapeuticsKhosrow Kashfi
Trends in Molecular Medicine|July 10, 2004
Nitric-oxide-donating NSAIDs as agents for cancer preventionBasil Rigas, Khosrow Kashfi
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2005
Cancer prevention: a new era beyond cyclooxygenase-2Basil Rigas, Khosrow Kashfi
Biochemical and Biophysical Research Communications|May 22, 2007
The mechanism of action of nitric oxide-donating aspirinKhosrow Kashfi, Basil Rigas
Biochemical Pharmacology|March 8, 2020
Tumor associated macrophages and 'NO'Niharika Nath, Khosrow Kashfi
Pageof 16